Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA

John C. Lainson, Seth M. Daly, Kathleen Triplett, Stephen Johnston, Pamela R. Hall, Chris Diehnelt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

One proposed solution to the crisis of antimicrobial resistant (AMR) infections is the development of molecules that potentiate the activity of antibiotics for AMR bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Rather than develop broad spectrum compounds, we developed a peptide that could potentiate the activity of a narrow spectrum antibiotic, oxacillin. In this way, the combination treatment could narrowly target the resistant pathogen and limit impact on host flora. We developed a peptide, ASU014, composed of a S. aureus binding peptide and a S. aureus inhibitory peptide conjugated to a branched peptide scaffold, which has modest activity against S. aureus but exhibits synergy with oxacillin for MRSA both in vitro and in a MRSA skin infection model. The low concentration of ASU014 and sub-MIC concentration of oxacillin necessary for activity suggest that this molecule is a candidate for future medicinal chemistry optimization.

Original languageEnglish (US)
Pages (from-to)853-857
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume8
Issue number8
DOIs
StatePublished - Aug 10 2017

Fingerprint

Oxacillin
Methicillin
Methicillin-Resistant Staphylococcus aureus
Peptides
Staphylococcus aureus
Anti-Bacterial Agents
Molecules
Pharmaceutical Chemistry
Pathogens
Infection
Scaffolds
Bacteria
Skin

Keywords

  • antibacterial peptide
  • MRSA
  • oxacillin
  • potentiator

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Cite this

Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA. / Lainson, John C.; Daly, Seth M.; Triplett, Kathleen; Johnston, Stephen; Hall, Pamela R.; Diehnelt, Chris.

In: ACS Medicinal Chemistry Letters, Vol. 8, No. 8, 10.08.2017, p. 853-857.

Research output: Contribution to journalArticle

Lainson, John C. ; Daly, Seth M. ; Triplett, Kathleen ; Johnston, Stephen ; Hall, Pamela R. ; Diehnelt, Chris. / Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA. In: ACS Medicinal Chemistry Letters. 2017 ; Vol. 8, No. 8. pp. 853-857.
@article{2372db51a1b246c5b580aa4e40cc27c5,
title = "Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA",
abstract = "One proposed solution to the crisis of antimicrobial resistant (AMR) infections is the development of molecules that potentiate the activity of antibiotics for AMR bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Rather than develop broad spectrum compounds, we developed a peptide that could potentiate the activity of a narrow spectrum antibiotic, oxacillin. In this way, the combination treatment could narrowly target the resistant pathogen and limit impact on host flora. We developed a peptide, ASU014, composed of a S. aureus binding peptide and a S. aureus inhibitory peptide conjugated to a branched peptide scaffold, which has modest activity against S. aureus but exhibits synergy with oxacillin for MRSA both in vitro and in a MRSA skin infection model. The low concentration of ASU014 and sub-MIC concentration of oxacillin necessary for activity suggest that this molecule is a candidate for future medicinal chemistry optimization.",
keywords = "antibacterial peptide, MRSA, oxacillin, potentiator",
author = "Lainson, {John C.} and Daly, {Seth M.} and Kathleen Triplett and Stephen Johnston and Hall, {Pamela R.} and Chris Diehnelt",
year = "2017",
month = "8",
day = "10",
doi = "10.1021/acsmedchemlett.7b00200",
language = "English (US)",
volume = "8",
pages = "853--857",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA

AU - Lainson, John C.

AU - Daly, Seth M.

AU - Triplett, Kathleen

AU - Johnston, Stephen

AU - Hall, Pamela R.

AU - Diehnelt, Chris

PY - 2017/8/10

Y1 - 2017/8/10

N2 - One proposed solution to the crisis of antimicrobial resistant (AMR) infections is the development of molecules that potentiate the activity of antibiotics for AMR bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Rather than develop broad spectrum compounds, we developed a peptide that could potentiate the activity of a narrow spectrum antibiotic, oxacillin. In this way, the combination treatment could narrowly target the resistant pathogen and limit impact on host flora. We developed a peptide, ASU014, composed of a S. aureus binding peptide and a S. aureus inhibitory peptide conjugated to a branched peptide scaffold, which has modest activity against S. aureus but exhibits synergy with oxacillin for MRSA both in vitro and in a MRSA skin infection model. The low concentration of ASU014 and sub-MIC concentration of oxacillin necessary for activity suggest that this molecule is a candidate for future medicinal chemistry optimization.

AB - One proposed solution to the crisis of antimicrobial resistant (AMR) infections is the development of molecules that potentiate the activity of antibiotics for AMR bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Rather than develop broad spectrum compounds, we developed a peptide that could potentiate the activity of a narrow spectrum antibiotic, oxacillin. In this way, the combination treatment could narrowly target the resistant pathogen and limit impact on host flora. We developed a peptide, ASU014, composed of a S. aureus binding peptide and a S. aureus inhibitory peptide conjugated to a branched peptide scaffold, which has modest activity against S. aureus but exhibits synergy with oxacillin for MRSA both in vitro and in a MRSA skin infection model. The low concentration of ASU014 and sub-MIC concentration of oxacillin necessary for activity suggest that this molecule is a candidate for future medicinal chemistry optimization.

KW - antibacterial peptide

KW - MRSA

KW - oxacillin

KW - potentiator

UR - http://www.scopus.com/inward/record.url?scp=85027226560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027226560&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.7b00200

DO - 10.1021/acsmedchemlett.7b00200

M3 - Article

AN - SCOPUS:85027226560

VL - 8

SP - 853

EP - 857

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 8

ER -